Crossmark

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Crossref DOI link: https://doi.org/10.1186/s12967-018-1425-7

Published Online: 2018-03-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lindström, Erik

Rizoska, Biljana https://orcid.org/0000-0002-9946-7174
Tunblad, Karin

Edenius, Charlotte

Bendele, Alison M.

Maul, Don

Larson, Michael

Shah, Neha

Yoder Otto, Valerie

Jerome, Chris

Grabowska, Urszula
License Information

Text and Data Mining valid from 2018-03-09
More Information

Article History

Received: 12 October 2017

Accepted: 24 February 2018

First Online: 9 March 2018